DaVita (NYSE:DVA) Releases FY 2022 Earnings Guidance

DaVita (NYSE:DVAGet Rating) updated its FY 2022 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $7.50-$8.50 for the period, compared to the consensus estimate of $7.87. The company issued revenue guidance of -.

Analyst Ratings Changes

Several brokerages have recently commented on DVA. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of DaVita from $150.00 to $97.00 and set a buy rating on the stock in a research report on Tuesday. Bank of America decreased their price objective on shares of DaVita from $110.00 to $90.00 and set an underperform rating on the stock in a research report on Tuesday, June 21st. Barclays decreased their price objective on shares of DaVita from $128.00 to $103.00 and set an equal weight rating on the stock in a research report on Thursday. StockNews.com downgraded shares of DaVita from a strong-buy rating to a buy rating in a research report on Thursday, May 5th. Finally, Truist Financial decreased their price objective on shares of DaVita from $110.00 to $90.00 and set a hold rating on the stock in a research report on Wednesday, June 22nd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, DaVita presently has an average rating of Hold and a consensus price target of $106.00.

DaVita Trading Up 0.4 %

Shares of DVA stock traded up $0.37 during trading hours on Friday, reaching $85.68. 612,743 shares of the stock were exchanged, compared to its average volume of 820,509. DaVita has a 12-month low of $74.97 and a 12-month high of $134.47. The company has a current ratio of 1.41, a quick ratio of 1.25 and a debt-to-equity ratio of 11.69. The company’s 50-day moving average price is $86.75 and its 200-day moving average price is $102.40. The firm has a market capitalization of $7.82 billion, a price-to-earnings ratio of 10.63, a price-to-earnings-growth ratio of 1.31 and a beta of 1.16.

DaVita (NYSE:DVAGet Rating) last announced its quarterly earnings data on Monday, August 1st. The company reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.21. DaVita had a net margin of 7.17% and a return on equity of 84.69%. The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $2.93 billion. During the same quarter last year, the business posted $2.64 EPS. The firm’s revenue for the quarter was up .4% on a year-over-year basis. As a group, equities analysts anticipate that DaVita will post 7.68 earnings per share for the current year.

Insider Activity

In other DaVita news, COO Michael David Staffieri purchased 20,000 shares of DaVita stock in a transaction dated Thursday, June 23rd. The stock was acquired at an average price of $77.70 per share, for a total transaction of $1,554,000.00. Following the acquisition, the chief operating officer now owns 61,190 shares in the company, valued at approximately $4,754,463. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. In other DaVita news, COO Michael David Staffieri purchased 20,000 shares of DaVita stock in a transaction dated Thursday, June 23rd. The stock was acquired at an average price of $77.70 per share, for a total transaction of $1,554,000.00. Following the acquisition, the chief operating officer now owns 61,190 shares in the company, valued at approximately $4,754,463. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Barbara J. Desoer sold 2,320 shares of the business’s stock in a transaction that occurred on Friday, June 3rd. The stock was sold at an average price of $97.42, for a total transaction of $226,014.40. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of DVA. Parkside Financial Bank & Trust grew its position in DaVita by 88.6% during the 1st quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock worth $35,000 after purchasing an additional 147 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in DaVita by 847.8% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,090 shares of the company’s stock worth $123,000 after purchasing an additional 975 shares during the last quarter. Eqis Capital Management Inc. purchased a new stake in DaVita during the 1st quarter worth approximately $210,000. Wetherby Asset Management Inc. grew its position in DaVita by 8.1% during the 1st quarter. Wetherby Asset Management Inc. now owns 2,050 shares of the company’s stock worth $232,000 after purchasing an additional 154 shares during the last quarter. Finally, Prudential PLC purchased a new stake in DaVita during the 1st quarter worth approximately $239,000. Institutional investors own 87.47% of the company’s stock.

About DaVita

(Get Rating)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More

Earnings History and Estimates for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.